Company intelligence / Profile preview

Lyric Bio

Unknown, Unknown, United Stateslyricbio.com ↗

Ownership: Private
Development stage: Preclinical

01

Overview

Developing next-generation bioreactors to produce human Ig with higher efficiency than plasma donation; aims to reduce costs, increase supply stability, and improve quality.

Therapeutic areas: Immunology
Modalities: Human immunoglobulin products (Ig)Complex therapeutics including proteins derived from human cells
Industry: Non-Drug Biotech

02

Drug pipeline

1 asset

immunoglobulin

Pre-clinical

Beyond the preview

Go deeper on Lyric Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lyric Bio.

Explore the full profile